Enalaprilat (Cardinal Health)
Welcome to the PulseAid listing for the Enalaprilat drug offered from Cardinal Health. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | Enalaprilat |
SUBSTANCE NAME: | ENALAPRILAT |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-08-23 |
END MARKETING DATE: | 0000-00-00 |
Enalaprilat HUMAN PRESCRIPTION DRUG Details:
Item Description | Enalaprilat from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.25(mg/mL) |
START MARKETING DATE: | 2000-08-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55154-0355_24878502-9383-4c4f-903c-8895fda20742 |
PRODUCT NDC: | 55154-0355 |
APPLICATION NUMBER: | ANDA075634 |
Other ENALAPRILAT Pharmaceutical Manufacturers / Labelers: